Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sara Monti and Roberto Caporali.
Sara Monti
Connection Strength
2.563
Roberto Caporali
  1. Randomized controlled trials and real-world data: differences and similarities to untangle literature data. Rheumatology (Oxford). 2018 10 01; 57(57 Suppl 7):vii54-vii58.
    View in: PubMed
    Score: 0.788
  2. Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors. Mod Rheumatol. 2018 May; 28(3):542-549.
    View in: PubMed
    Score: 0.732
  3. Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. Clin Rheumatol. 2017 Apr; 36(4):753-761.
    View in: PubMed
    Score: 0.699
  4. 20 years of experience with tumour necrosis factor inhibitors: what have we learned? Rheumatology (Oxford). 2018 10 01; 57(57 Suppl 7):vii5-vii10.
    View in: PubMed
    Score: 0.197
  5. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data? Arthritis Rheumatol. 2020 10; 72(10):1600-1606.
    View in: PubMed
    Score: 0.056
  6. How I treat idiopathic patients with inflammatory myopathies in the clinical practice. Autoimmun Rev. 2017 Oct; 16(10):999-1007.
    View in: PubMed
    Score: 0.045
  7. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol. 2017 Mar-Apr; 35 Suppl 103(1):194-198.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.